HENDERSON, Nev., April 29, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces a major technical milestone with the successful detection of nucleosomes in capillary blood from critically ill sepsis patients...
Hence then, the article about volition announces breakthrough finger prick detection of nucleosomes expanding global market potential for sepsis testing was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing )
Also on site :
- PSG vs Barcelona: Kick-Off Time, Expected Lineups and How to Watch the Champions League Clash
- Sarah J. Maas Urges ‘ACOTAR’ Fans Not to Share Leaks Ahead of New Book: ‘Beyond Disheartening’
- Mark Wahlberg Stars as Notorious Hitman in 2026 Thriller The Guardian Called ‘Grimly Effective’ Now Out on Digital